Monteris Medical, a medical device company formed in Winnipeg in 1999, has received Health Canada clearance to make its MRI-guided, minimally invasive surgical laser device commercially available in Canada.
The device called NeuroBlate (formerly known as AutoLITT) is used to treat deep-seated, and difficult-to-treat brain tumours and epilepsy.
Monteris has had regulatory approval to sell the device in the U.S. since 2010 and there are six installation sites in action there.
The privately held medical device company continues to maintain engineering, software development and technical offices in Winnipeg at its Smartpark location, with more than 25 employees. The company has executive and sales offices in the Minneapolis area.
Prior to this approval, a "special access waiver" has been granted for patients of Dr. Brian Toyota, in Vancouver. He’s now tooled up to have the technology ready for patients soon.
In a prepared statement Dr. Toyota said, "I am very enthused to have the first-in-Canada NeuroBlate System placed in Vancouver. It is an exciting and innovative technology that represents a powerful treatment option. I am confident it will have a significant impact on the management of, and outcomes for, Canadians suffering from brain tumours."